<html lang="en">

<head>
  <title>Pediatric Urinary Tract Infection</title>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1.0" />
  <link rel="stylesheet" href="cpgPedEr.css" />

</head>

<body>
  <div id="header-container"></div>
  <header class="page-header">Pediatric Urinary Tract Infection</header>
  <div class="container">

    <p class="cpg-headers">DEFINITION</p>
    <ul>
      <li><strong>Symptomatic bacteriuria</strong>: Upper or lower urinary tract symptoms and urine culture with
        significant bacterial colony counts</li>
      <li><strong>Urethritis</strong>: Inflammation of the urethral mucosa, with symptoms of Dysuria, frequency,
        secondary enuresis, pyuria, and low urine colony counts (&lt;10<sup>3</sup>) (rule out vaginitis in sexually
        active patients).</li>
      <li><strong>Acute cystitis</strong>: Inflammation of bladder mucosa and symptoms of lower tract infections:
        urgency, dysuria, frequency, and hematuria.</li>
      <li><strong>Parenchyma infection/acute pyelonephritis:</strong>&nbsp;Inflammation of renal parenchyma and symptoms
        of upper tract infection: high fever (temperature &gt;39C), abdominal or flank pain, and other systemic symptoms
        (eg, vomiting).</li>
      <li><strong>Asymptomatic bacteriuria</strong>: Urine culture with significant bacterial colony count in an
        asymptomatic patient.</li>
      <li><strong>Complicated bacteriuria:</strong>&nbsp;Urine culture with significant bacterial colony count and
        associated urologic abnormalities (hydroureter, hydronephrosis, and vesicoureteral reflux).</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">CLINICAL SYMPTOMS AND SIGNS</p>
    <ul>
      <li><strong>0-3 months</strong>&nbsp;symptoms nonspecific: fever, hypothermia, vomiting, diarrhea, jaundice,
        difficulty feeding, malodorous urine, irritability, hematuria, or failure to thrive.</li>
      <li><strong>3-24 months</strong>&nbsp;more specific symptoms: cloudy or malodorous urine, frequency, or hematuria
      </li>
      <li><strong>2-6 years</strong>&nbsp;of age-specific symptoms: abdominal pain, suprapubic pain, costovertebral
        angle pain, dysuria, urgency, or secondary enuresis in a previously toilet-trained child.</li>
      <li><strong>Temperature &gt; 38.5C&nbsp;</strong>helps to differentiate acute pyelonephritis from lower tract
        UTIs.</li>
      <li>Fever can be the only symptom<strong>.</strong></li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">DIAGNOSIS</p>
    <ul>
      <li><strong>Urine culture</strong>
        <ul>
          <li>Gold standard for UTI diagnosis</li>
          <li>Obtained by suprapubic aspiration (SPA), urethral catheterization, a clean catch midstream specimen, or
            urine bag collection (least preferable).</li>
          <li>88% false positive in bag sample.</li>
          <li>Urine specimen is obtained for both culture and urinalysis before an antimicrobial agent is administered.
          </li>
          <li>To establish the diagnosis of UTI, clinicians should require both</li>
          <ul>
            <li>Urinalysis results that suggest infection (pyuria and/or bacteriuria)</li>
            <li>50,000 colony-forming units (CFUs) per mL of a uropathogen cultured from a urine specimen obtained
              through catheterization or SPA.</li>
          </ul>
          <li>Suprapubic Aspiration: Any growth of gram-negative bacilli.</li>
        </ul>
      </li>
      <li>&nbsp;<strong>Nitrite</strong>
        <ul>
          <li>Nitrate converted to nitrite by gram negative bacteria</li>
          <li>37% sensitive and 100% specific</li>
          <li>Positive predictive value and negative predictive value of 90% and 100%</li>
        </ul>
      </li>
      <li>&nbsp;<strong>Leukocyte esterase</strong>
        <ul>
          <li>Sensitivity and specificity is 73%</li>
          <li>Positive predictive value is 34%, and the negative predictive value is 95%.</li>
        </ul>
      </li>
      <li>&nbsp;<strong>Pyuria</strong>
        <ul>
          <li>Not adequate to diagnose a UTI and is not a substitute for a urine culture.</li>
          <li>May be related to vaginal secretions, dehydration, glomerulonephritis, tuberculosis, or interstitial
            nephritis and should be differentiated from a UTI.</li>
        </ul>
      </li>
      <li>&nbsp;<strong>Microbiology</strong>
        <ul>
          <li>Escherichia coli 70% of infections.</li>
        </ul>
      </li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">RISK FACTORS FOR SEVERE DISEASE</p>
    <ul>
      <li>Age &lt; 12 mo</li>
      <li>Temp &ge; 39 <sup> â—¦ </sup> C</li>
      <li>Fever &ge; 2 d</li>
      <li>Constipation</li>
      <li>Infrequent voiding pattern</li>
      <li>Antenatally diagnosed urinary tract abnormality</li>
      <li>Family history of vesico-ureteric reflux</li>
      <li>Evidence of spinal lesion</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">Management and Treatment</p>

    <p class="cpg-sub-headers">Antibiotics</p>
    <ul>
      <li>Initiating treatment orally or parenterally is equally efficacious</li>
      <li>Choice of route of administration on practical considerations</li>
      <li>The choice of agent on local antimicrobial sensitivity patterns</li>
      <li>Adjust the choice according to sensitivity testing of the isolated uropathogen.</li>
      <li>The clinician should choose&nbsp;<u>7-14 days</u>&nbsp;as the duration of antimicrobial therapy</li>
      <li>When there is prolonged fever or renal abscess, treating for up to 14 days may be reasonable.</li>
      <li>In most cases with appropriate treatment, the cultures become sterile by 48 hours</li>
    </ul>

    <p class="cpg-sub-headers">ANTIBIOTIC TYPES</p>
    <ul>
      <li>Pyelonephritis
        <ul>
          <li>Ceftriaxone (50-75 mg/kg/24 hr not to exceed 2 g)</li>
          <li>Cefotaxime (100 mg/kg/24 hr)</li>
          <li>ampicillin (100 mg/kg/24 hr) with an aminoglycoside such as gentamicin (3-5 mg/kg/24 hr in 1-3 divided
            doses)</li>
        </ul>
      </li>
      <li>Cystitis
        <ul>
          <li>Trimethoprim-sulfamethoxazole (TMP-SMX) a 3-5-day</li>
          <li>Nitrofurantoin (5-7 mg/kg/24 hr in 3-4 divided doses)</li>
        </ul>
      </li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">HOSPITALIZATION INDICATIONS</p>
    <ul>
      <li>3 Months and younger should be hospitalized to receive intravenous fluids and antibiotics.</li>
      <li>Clinical urosepsis (eg, toxic appearance, hypotension, poor capillary refill)</li>
      <li>Dehydration or the inability to take oral fluids.</li>
      <li>Vomiting or inability to tolerate oral medications</li>
      <li>Lack of adequate outpatient follow-up (eg, no telephone, live far from hospital, etc.)</li>
      <li>Failure to respond to outpatient therapy</li>
      <li>Chronic diseases such as sickle cell disease, diabetes mellitus, immunocompromised, cystic fibrosis, urinary
        tract abnormalities, or other serious conditions when the infection could compromise the chronic illness.</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">ULTRASOUND</p>

    <ul>
      <li>Febrile infants with UTIs should undergo renal and bladder ultrasonography (RBUS).</li>
      <li>Renal Ultrasonography is Safe and fast.</li>
      <li>Not a good imaging for diagnosing VUR in low-grade VUR.</li>
      <li>Not sensitive for diagnosing renal scars or acute pyelonephritis.</li>
      <li>The timing of RBUS is usually during hospitalization for inpatients and within 2-4 weeks for outpatients.</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">VCUG</p>
    <ul>
      <li>The gold standard for diagnosing VUR</li>
      <li>VCUG should not be performed routinely after the first febrile UTI</li>
      <li>VCUG is indicated if</li>
      <ul>
        <li>RBUS reveals hydronephrosis, scarring, or other findings that would suggest either high-grade VUR or
          obstructive uropathy.</li>
        <li>Other atypical or complex clinical circumstances.</li>
      </ul>
      <li>VCUG with further evaluation should be conducted if there is a recurrence of febrile UTI<strong>.</strong>
      </li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">FOLLOW-UP</p>
    <p class="cpg-text">After confirmation of UTI, the clinician should instruct parents or guardians to seek prompt
      medical evaluation (ideally within 48 hours) for future febrile illnesses, to ensure that recurrent infections can
      be detected and treated promptly rather than on&nbsp;<strong>regularly</strong>&nbsp;repeated urine cultures after
      treatment.</p>

    <table class="cpg-table">
      <tr>
        <th colspan="4">Criteria when to do US, DMSA, MCUG</th>
      </tr>
      <tr>
        <td>Test</td>
        <td>Simple UTI</td>
        <td>Atypical UTI</td>
        <td>Recurrent UTI</td>
      </tr>
      <tr>
        <td></td>
        <td></td>
        <td>
          Seriously ill
          <br>Poor urine flow
          <br>Abdominal or bladder mass
          <br>Raised creatinine
          <br>Septicemia
          <br>Failure to respond to treatment with suitable antibiotics within 48 hours
          <br>Infection with non-E. Coli
        </td>
        <td>
          one or more episodes of UTI with acute pyelonephritis/upper urinary tract infection,
          <br>one episode of UTI with acute pyelonephritis/upper urinary tract infection plus one or more episode of UTI
          with cystitis/lower urinary tract infection, or
          <br>Three or more episodes of UTI with cystitis/lower urinary tract infection.
        </td>
      </tr>
      <tr>
        <td style="background-color:rgb(207, 207, 207);text-align: center;" colspan="4"><b>Aged 0-6 months</b></td>
      </tr>
      <tr>
        <td>US during acute infection</td>
        <td>No</td>
        <td>Yes</td>
        <td>Yes</td>
        </td>
      </tr>
      <tr>
        <td>US within 6 weeks</td>
        <td>Yes</td>
        <td>No</td>
        <td>No</td>
      </tr>
      <tr>
        <td>DMSA</td>
        <td>No</td>
        <td>Yes</td>
        <td>Yes</td>
      </tr>
      <tr>
        <td>MCUG</td>
        <td>Consider if US is abnormal</td>
        <td>Yes</td>
        <td>Yes</td>
      </tr>
      <tr>
        <td style="background-color:rgb(207, 207, 207);text-align: center;" colspan="4"><b>Aged 6 months - 3 years</b>
        </td>
      </tr>
      <tr>
        <td>US during acute infection</td>
        <td>No</td>
        <td>Yes</td>
        <td>No</td>
      </tr>
      <tr>
        <td>US within 6 weeks</td>
        <td>No</td>
        <td>No</td>
        <td>Yes</td>
      </tr>
      <tr>
        <td>DMSA</td>
        <td>No</td>
        <td>Yes</td>
        <td>Yes</td>
      </tr>
      <td>MCUG</td>
      <td>No</td>
      <td colspan="2">Not routine; consider if dilation on ultrasound, poor urine flow, nonE. coli infection, or family
        history of vesicoureteric reflux</td>
      </tr>
      <tr>
        <td style="background-color:rgb(207, 207, 207);text-align: center;" colspan="4"><b>Aged &gt;3 yr</b></td>
      </tr>
      <tr>
        <td>US during acute infection</td>
        <td>No</td>
        <td>Yes</td>
        <td>No</td>
      </tr>
      <tr>
        <td>US within 6 weeks</td>
        <td>No</td>
        <td>No</td>
        <td>Yes</td>
      </tr>
      <tr>
        <td>DMSA</td>
        <td>No</td>
        <td>Yes</td>
        <td>Yes</td>
      </tr>
      <tr>
        <td>MCUG</td>
        <td>No</td>
        <td>No</td>
        <td>No</td>
      </tr>
    </table>

    <br>
    <div class="border-btm"></div>
    <p class="cpg-headers">VESICOURETERAL REFLUX</p>

    <ul>
      <li>Resolution</li>
      <li>All grades of primary VUR have the potential for spontaneous resolution over a period of time.</li>
      <li>Resolution rate in Children younger than 5 years of age
        <ul>
          <li>Grade I 82%</li>
          <li>Grade II 80%</li>
          <li>Grade III 46%</li>
          <li>Grade IV 30%</li>
          <li>Grade V 13%</li>
        </ul>
      </li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">VESICOURETERAL REFLUX TREATMENT</p>

    <ul>
      <li><strong>No statistically significant benefit</strong>&nbsp;could be demonstrated
        for&nbsp;<strong>prophylaxis</strong>&nbsp;in those without VUR or those with grades I to IV VUR&nbsp;</li>
      <li>Long-term antimicrobial prophylaxis can protect from repeated UTIs in grade "IV" and "V" but it increases the
        risk of resistant bacteria&nbsp;</li>
      <li>Antimicrobial agents
        <ul>
          <li>trimethoprim-sulfamethoxazole (TMP-SMZ) (avoided in neonates)</li>
          <li>trimethoprim alone</li>
          <li>nitrofurantoin</li>
          <li>cephalexin</li>
          <li>Ampicillin and amoxicillin
            <ul>
              <li>less effective (E coli resistance)</li>
              <li>Used in the first 2 postnatal months</li>
            </ul>
          </li>
        </ul>
      </li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-sub-headers">Vesicoureteral Reflux medication doses</p>
    <ul>
      <li>Â¼ to Â½ to the therapeutic dose for acute infection</li>
      <li>TMP-SMZ: TMP 2 mg/kg as a single dose or 5 mg/kg of TMP twice per week</li>
      <li>Nitrofurantoin: 1 to 2 mg/kg as a single daily dose</li>
      <li>Cephalexin: 10 mg/kg as a single daily dose</li>
      <li>Ampicillin: 20 mg/kg as a single daily dose</li>
      <li>Amoxicillin: 10 mg/kg as a single daily dose</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-sub-headers">DURATION</p>
    <ul>
      <li>Depend on the age of the patient, the severity of the VUR, the frequency of UTI, patient tolerance, compliance
        with antimicrobial prophylaxis, presence and severity of renal scarring, and duration of follow-up.&nbsp;</li>
      <li>Medical management is appropriate for all grades of primary VUR, particularly in younger children&nbsp;</li>
      <li>Surgical management is reserved for patients who fail medical management by having breakthrough UTIs or
        persistent VUR, particularly with evidence of progressive renal injury.&nbsp;</li>
      <li>Medical management must include treatment of constipation and voiding dysfunction if present.</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-sub-headers">Follow-up VCUG</p>
    <ul>
      <li>Not well defined</li>
      <li>Yearly studies</li>
      <li>Every 2 years in children who have mild VUR (grades I and II)</li>
      <li>Every 3 years in children who have moderate/severe VUR (grades III or higher)</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">NEUROGENIC BLADDER</p>

    <ul>
      <li>Urine may be colonized with gram-negative bacteria</li>
      <li>There is no evidence that chronic bacteriuria in patients who have had neurogenic bladder is associated with
        renal damage</li>
      <li>Only <strong>symptomatic UTIs</strong> should be treated&nbsp;</li>
      <li>Attempts to sterilize the urine for prolonged periods with prophylactic or active treatment
        <ul>
          <li>Usually fail</li>
          <li>This leads to the emergence of highly resistant strains</li>
          <li>Colonization of more</li>
        </ul>
      </li>
      <li>Symptoms suggestive of UTI
        <ul>
          <li>Fever</li>
          <li>Abdominal or loin pain</li>
          <li>Dysuria (minimal in the neurogenic bladder)</li>
          <li>Change in color or odor of urine</li>
        </ul>
      </li>
      <li>Factors that help in decreasing UTI
        <ul>
          <li>Intermittent catheterization</li>
          <li>Constipation treatment</li>
          <li>Proper hygiene</li>
          <li>Anticholinergic</li>
        </ul>
      </li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">NEONATES WITH DILATED RENAL PELVIS</p>
    <ul>
      <li>All newborns with a history of prenatal dilated pelvis should have a confirmatory ultrasound postnatally.</li>
      <li>If no dilation is found on the initial sonogram, repeat the study every three months till resolved if it
        didn't resolve spacing of scans can be done (6 months to 1 year).</li>
      <li>The majority of cases with mild or moderate postnatal hydronephrosis resolve by 18 months of age</li>
      <li>If there is unilateral or bilateral hydronephrosis follow the below recommendations.</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">UNILATERAL FETAL HYDRONEPHROSIS</p>
    <ul>
      <li>Fetal hydronephrosis (prenatal RPD &gt;10 mm on an antenatal ultrasound performed in the third trimester) with
        a normal-appearing contralateral kidney, ultrasonography should be performed when the infant returns to birth
        weight usually within the first two to four weeks of life
        <ul>
          <li>&lt;10 mm Normal or mild hydronephrosis. Grade 1.</li>
          <li>10 to 15 mm Moderate hydronephrosis. Grade 2.</li>
          <li>&gt;15 mm Severe hydronephrosis; these infants are at the greatest risk for significant kidney disease,
            which may require surgical correction. SFU grades 3 and 4.&nbsp;</li>
        </ul>
      </li>
      <li>Persistent moderate to severe hydronephrosis requires VCUG to rule out VUR (9%). If the VCUG does not show
        VUR, further evaluation is dependent on the degree of hydronephrosis (same like bilateral hydronephrosis).&nbsp;
      </li>
      <li>Persistent Severe hydronephrosis requires referral for VCUG and MAG3</li>
    </ul>

    <img class="image" width="600" height="604" id="Picture 2691" src="uti_files/image001.gif" alt="Hydronephrosis managment pathway">

    <div class="border-btm"></div>
    <p class="cpg-headers">DISCHARGE CRITERIA</p>
    <ul>
      <li>The patient afebrile for at least 24 hours</li>
      <li>Can tolerate oral intake and oral medications</li>
      <li>Appropriate oral antibiotics are available</li>
    </ul>

    <div class="border-btm"></div>
    <p class="cpg-headers">DISCHARGE PLAN/INSTRUCTIONS</p>
    <ul>
      <li>Radiology investigations arranged</li>
      <li>Follow-up appointment arranged</li>
      <li>Patient/Family education performed</li>
      <li>Discharge summary completed</li>
    </ul>
  </div>

  <script src="/js/header.js"></script>
</body>

</html>